Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | 0.00% | +36.59% | -20.00% |
May. 03 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
May. 03 | Ondine Biomedical to Raise GBP3 Million Via Placing, Subscription | MT |
Business Summary
Number of employees: 18
Sales per Business
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Antimicrobial Photodynamic Therapy
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -73.30% |
Sales per region
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
93.4
%
| 1 | 97.4 % | 0 | 93.4 % | -74.38% |
Other
6.6
%
| 0 | 2.6 % | 0 | 6.6 % | -33.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Bill Kanz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jason Hickok
CTO | Chief Tech/Sci/R&D Officer | - | - |
Roger Andersen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Simon Sinclair
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-12-06 |
Angelika Vance
IRO | Public Communications Contact | - | - |
Tom Dawson
PRN | Corporate Officer/Principal | - | - |
Nikita Parkhaev
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 21-12-06 |
Carolyn Cross
FOU | Founder | 62 | 96-09-08 |
Nicolas Loebel
PSD | President | 64 | 04-02-29 |
Jean Duvall
BRD | Director/Board Member | 63 | 21-12-06 |
Mike Farrar
BRD | Director/Board Member | 64 | 21-12-06 |
Jean Charest
CHM | Chairman | 65 | 18-02-07 |
Junaid Bajwa
BRD | Director/Board Member | 45 | 21-12-06 |
Simon Sinclair
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-12-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 194,983,407 | 7,499,533 ( 3.846 %) | 0 | 22.43 % |
Stock B | 0 | 225,617,679 | 86,854,210 ( 38.50 %) | 0 |
Company contact information
Ondine Biomedical, Inc.
1100 Melville Street Suite 888
V6E 4A6, Vancouver
+604-669-0555
http://www.ondinebio.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 19.86M | |
-4.91% | 182B | |
+0.46% | 110B | |
-3.62% | 67.92B | |
+3.26% | 50.96B | |
+9.11% | 44.7B | |
+2.50% | 40.66B | |
+6.39% | 27.6B | |
+3.83% | 26.63B | |
+14.13% | 24.84B |
- Stock Market
- Equities
- OBI Stock
- Company Ondine Biomedical Inc.